1. Home
  2. CNXC vs ANIP Comparison

CNXC vs ANIP Comparison

Compare CNXC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

N/A

Current Price

$33.91

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$74.66

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXC
ANIP
Founded
1991
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
CNXC
ANIP
Price
$33.91
$74.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$69.00
$107.33
AVG Volume (30 Days)
1.3M
318.7K
Earning Date
04-15-2026
05-11-2026
Dividend Yield
4.10%
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
$9,825,771,000.00
$206,547,000.00
Revenue This Year
$5.17
$19.88
Revenue Next Year
$2.51
$15.77
P/E Ratio
N/A
$22.35
Revenue Growth
2.15
2.47
52 Week Low
$29.35
$56.71
52 Week High
$66.00
$99.50

Technical Indicators

Market Signals
Indicator
CNXC
ANIP
Relative Strength Index (RSI) 48.83 41.34
Support Level $31.63 $74.28
Resistance Level $44.40 $85.12
Average True Range (ATR) 1.85 2.61
MACD 0.60 -0.05
Stochastic Oscillator 81.68 31.01

Price Performance

Historical Comparison
CNXC
ANIP

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: